vanguard cc b oral
zoetis new zealand limited - bordetella bronchiseptica - bi strain - bordetella bronchiseptica - bi strain 0 vaccine - vaccine
versican plus bb oral lyophilisate and solvent for oral suspension for dogs
zoetis belgium s.a. - bordetella bronchiseptica, live - lyophilisate and solvent for oral suspension - . - bordetella
nobivac respira bb suspension for injection for dogs
intervet ireland limited - bordetella bronchiseptica fimbriae - suspension for injection - . - bordetella
nobivac respira bb suspension for injection in pre-filled syringe for dogs
intervet ireland limited - bordetella bronchiseptica fimbriae - suspension for injection in pre-filled syringe - . - bordetella
versican plus bbpi in nasal drops, lyophilisate and solvent for suspension for dogs
zoetis belgium s.a. - bordetella bronchiseptica, live; canine parainfluenza virus, live - lyophilisate and solvent for suspension for nasal administration - . - bordetella + canine parainfluenza virus
nobivac canine oral bb
schering-plough animal health limited - bordetella bronchiseptica (attenuated) - bordetella bronchiseptica (attenuated) 0 vaccine - vaccine
rhiniseng formulation: each 2 ml (dose) contains: inactivated bordetella bronchiseptica (strain 833cer) > 10^98 bbcc recombinant pasteurella multicoda (pmtr) type d > 1 med63 bcc - bordetella bronchiseptica cell count med: murine effective dose suspension for injection (im)
hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated vaccine against porcine atrophic rhinitis - suspension for injection (im) - formulation: each 2 ml (dose) contains: inactivated bordetella bronchiseptica (strain 833cer) > 10^98 bbcc recombinant pasteurella multicoda (pmtr) type d > 1 med63 bcc - bordetella bronchiseptica cell count med: murine effective dose
vanguard cc 3 intranasal
zoetis new zealand limited - canine parainfluenza virus - nl-cpi-5; bordetella bronchiseptica - bi strain; canine adenovirus type 2 - manhattan - canine parainfluenza virus - nl-cpi-5 0 vaccine; bordetella bronchiseptica - bi strain 0 vaccine; canine adenovirus type 2 - manhattan 0 vaccine - vaccine
respisure one mycoplasma hyopneumoniae vaccine
zoetis australia pty ltd - mycoplasma hyopneumoniae - inactivated antigen; thiomersal - misc. vaccines or anti sera - mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 31600.0 ru/2ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - mycoplasma hyopneumoniae | pneumonia | bacterial pneumonia | reduction of lung lesions | respiratory disease | swine enzootic pneumonia
canvac 4 in 1 + bb combination vaccine pack
csl limited - bordetella bronchiseptica (inactivated cell free extract | canine adeno virus type 2 | canine distemper virus - living | canine parainfluenza virus | canine parvo virus type 2 - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infectious canine hepatitis | infectious tracheobronchitis | parvovirus